Phenotypic expression of 19q13.32 microdeletions: Report of a new patient and review of the literature
- 14 April 2017
- journal article
- review article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 173 (7) , 1970-1974
Abstract
The phenotypic manifestations of microdeletions in the 19q13.32 region are still poorly known. In this paper we report a patient who presented with hypotonia, developmental delay, facial dysmorphism, micrognathia, kyphoscoliosis, and buried penis. Chromosomal microarray revealed an interstitial 327 kb de novo microdeletion in the 19q13.32 region comprising eight genes (ARGHAP35, NPAS1, TMEM160, ZC3H4, SAE1, BBC3, MIR3190, and MIR3191). Previously reported cases of microdeletions in the 19q13.32 region were reviewed and compared to our patient, highlighting the common features of a possible 19q13.32 microdeletion syndrome.Keywords
This publication has 9 references indexed in Scilit:
- NPAS1 Represses the Generation of Specific Subtypes of Cortical InterneuronsNeuron, 2014
- 19q13.32 microdeletion syndrome: Three new casesEuropean Journal of Medical Genetics, 2014
- LMX1B Is Part of a Transcriptional Complex with PSPC1 and PSFPLOS ONE, 2013
- A Discovery Resource of Rare Copy Number Variations in Individuals with Autism Spectrum DisorderG3: Genes, Genomes, Genetics, 2012
- Neurite outgrowth from PC12 cells by basic fibroblast growth factor (bFGF) is mediated by RhoA inactivation through p190RhoGAP and ARAP3Journal of Cellular Physiology, 2010
- A mechanosensitive transcriptional mechanism that controls angiogenesisNature, 2009
- Array-CGH detection of a de novo 0.8 Mb deletion in 19q13.32 associated with mental retardation, cardiac malformation, cleft lip and palate, hearing loss and multiple dysmorphic featuresEuropean Journal of Medical Genetics, 2009
- PUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53Science, 2005
- In VitroSUMO-1 Modification Requires Two Enzymatic Steps, E1 and E2Biochemical and Biophysical Research Communications, 1999